Odaily星球日报讯 港股上市公司领航医药生物科技有限公司（00399）宣布签署谅解备忘录，计划收购目标公司全部股权，前提是目标公司完成对 Conflux 区块链相关资产的收购。此次收购的价格将通过现金、公司股份或可换股债券支付，具体金额将在正式协议中确定。谅解备忘录有效期为 12 个月，在此期间，卖方不得与其他方就目标公司股权进行谈判或交易。领航医药希望通过这次收购扩展业务至区块链技术领域，实现业务多元化并寻找新的盈利增长点。但交易仍需签署正式协议后才能落实，相关公告将根据上市规则适时发布，股东及投资者需谨慎行事。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.